ClaritiDox
ClaritiDox is a US-based public benefit LLC providing clinical trial disclosure, regulatory medical writing, and data anonymization professional services to pharmaceutical and biotechnology clients globally.
- Company typePrivate
- Founded-
- HeadquartersWilmington, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What ClaritiDox does
ClaritiDox is a Wilmington, Delaware-based public benefit LLC that provides professional services to pharmaceutical and biotechnology companies across the clinical trial disclosure and regulatory writing lifecycle. Its portfolio spans six core service modules: Clinical Trial Disclosure (protocol registration, results posting, and XML development across ClinicalTrials.gov, CTIS/EudraCT, and UK registries), Data Anonymization (redaction and anonymization under EU CTR, EMA Policy 0070/0043, and Health Canada PRCI), Plain Language Authoring (lay summaries and informed consent content), Scientific Writing (INDs, BLA/NDA/MAAs, clinical study reports, briefing books), Document Quality Control and Editing, and Project Management. The firm positions itself as a tech-enabled services provider, partnering with third-party software vendors for anonymization and redaction tooling while relying on its in-house expert writers for delivery.
The company delivers through a globally distributed team across nine countries (US, Canada, India, Portugal, Philippines, France, England, Ireland, and Australia), enabling round-the-clock support and integration with client study teams across time zones. Its roster includes senior and above-level writers, PhD-level scientists, and physicians with over 20 years of writing experience and decades of combined clinical trial disclosure expertise, with documented therapeutic area coverage spanning oncology, respiratory, cardiovascular, CNS, rare diseases, and gene therapy. ClaritiDox has served over 25 pharma and biotech clients and reports cumulative delivery of more than 5,500 documents, 30 regulatory submissions, and 30 anonymization reports.
The business model is project-based professional services delivered through direct enterprise engagement; new business is sourced via the company website contact form, LinkedIn presence, and industry relationships rather than paid marketing channels. Pricing is not publicly disclosed, consistent with custom-scope contracts typical of specialized pharma services. The company operates as a privately held LLC with no disclosed institutional investors, funding rounds, or M&A activity.
ClaritiDox firmographics
Firmographics- Name
- ClaritiDox
- Legal name
- ClaritiDox
- Website
- https://claritidox.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- ClaritiDox is a US-based public benefit LLC providing clinical trial disclosure, regulatory medical writing, and data anonymization professional services to pharmaceutical and biotechnology clients globally.
- Ownership category
- akta.pro rank
ClaritiDox industry classification
Industry- Product category
- Medical Writing and Clinical Trial Disclosure Services
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Medical Writing & Regulatory Submission Support CROs (HLAGAAAG)
- akta.pro secondary industry
- Clinical CROs (Phase I–IV) (HLAGAAAA)
Keywords
Where ClaritiDox is headquartered
LocationHeadquarters
- HQ city
- Wilmington
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
ClaritiDox business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D
Revenue model
- Clinical Trial Disclosure Services: Professional services for protocol registration, redaction of study documents, XML development, gap analysis, results disclosure, and general advisory services for clinical trial registries such as ClinicalTrials.gov, CTIS/EudraCT, and UK registries.
- Data Anonymization and Redaction Services: Expert anonymization and redaction services for CTIS, manuscripts, ClinicalTrials.gov, Policy 0070, and PRCI submissions, including preparation of anonymization plans and final reports.
- Scientific and Regulatory Writing Services: Comprehensive writing services spanning preclinical to post-marketing phases, including submissions, strategic regulatory documents, nonclinical reports, briefing books, clinical study reports, and medical communications.
- Plain Language Authoring Services: Creation of plain-language summaries, informed consent documents, protocol synopses, and patient engagement content for clinical trials and public communication.
- Project Management and Administrative Services: Contract management, resource planning, data entry, and workflow management services for pharmaceutical clients.
- Document Quality Control and Editing Services: Thorough QC and editing review services including data consistency checks, line editing, formatting, style compliance, and template checks.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
ClaritiDox product offering
Product offeringCore offering
ClaritiDox is a public benefit company that delivers professional services for clinical trial disclosure, regulatory and scientific medical writing, and data anonymization/redaction to pharmaceutical and biotechnology clients. The firm provides protocol registration, results posting, document redaction, plain language summaries, regulatory submissions, document quality control, and project management support across global registries including ClinicalTrials.gov, CTIS/EudraCT, and UK registries.
Product overview
ClaritiDox is a clinical trial disclosure and medical writing services provider offering a unified portfolio of six interconnected service modules. The core offerings include Clinical Trial Disclosure (registration and results posting in global registries), Data Anonymization (redaction and anonymization for regulatory compliance), Plain Language Authoring (patient-facing summaries), Scientific Writing (regulatory and medical documents), Document Quality Control and Editing, and Project Management. These services are designed to work together as an integrated suite for pharmaceutical and biotechnology clients seeking end-to-end transparency and regulatory writing support.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Trial Disclosure
- Data Anonymization
- Plain Language Authoring
- Scientific Writing
- Document Quality Control and Editing
- Project Management
Quantifiable outcome
- Over 5,500 documents delivered
- +3 more outcomes
Companies that use ClaritiDox
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles3 records
ClaritiDox technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
ClaritiDox partnerships and signals
Strategic signalScale indicators5 records
Recent moves4 records
Expansion highlights4 records
ClaritiDox competitors and assessment
Company assessmentMarket position
Strengths4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
ClaritiDox social profiles
Digital presenceClaritiDox financial estimates
Financial estimateRevenue estimate
Valuation estimate
ClaritiDox leadership team
Management profileNumber of profiles
ClaritiDox funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ClaritiDox M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ClaritiDox
What does ClaritiDox do?
ClaritiDox is a public benefit company that delivers professional services for clinical trial disclosure, regulatory and scientific medical writing, and data anonymization/redaction to pharmaceutical and biotechnology clients. The firm provides protocol registration, results posting, document redaction, plain language summaries, regulatory submissions, document quality control, and project management support across global registries including ClinicalTrials.gov, CTIS/EudraCT, and UK registries.
Is ClaritiDox a public or private company?
ClaritiDox is a private company. It is classified as unknown and is currently operating.
When was ClaritiDox founded?
ClaritiDox was founded in -1. It employs 11 to 50 people.
Where is ClaritiDox based?
ClaritiDox is headquartered in Wilmington, United States, in the North America region.
How does ClaritiDox make money?
Six revenue lines are on record. Clinical Trial Disclosure Services are the primary driver. The others are data Anonymization and Redaction Services, scientific and Regulatory Writing Services, plain Language Authoring Services, project Management and Administrative Services and document Quality Control and Editing Services.
Does ClaritiDox have an API?
No public API is recorded for ClaritiDox.
What industry is ClaritiDox in?
ClaritiDox's product category is Medical Writing and Clinical Trial Disclosure Services. Its primary akta.pro industry code is HLAGAAAG, Medical Writing & Regulatory Submission Support CROs, with a secondary code of HLAGAAAA, Clinical CROs (Phase I–IV). Its NAICS code is 5417 and its SIC code is 8731.